Age-related macular degeneration, the leading cause of vision loss and blindness for Americans 65 and older, is a progressive disease affecting central vision. Over time, faces, book pages and ...

The European Medicines Agency (EMA) has announced its approval of two new biosimilar medications, Afqlir and Opuviz, to treat age-related macular degeneration (ARMD). The active ingredient of both ...

A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression of age-related macular degeneration, a leading cause of blindness in ...

A typical early symptom of age-related macular degeneration (AMD) is difficulty performing tasks under low-light conditions and in low-contrast surroundings. Patients may experience gradually ...

Fixing problems with cholesterol metabolism might help slow or prevent a common cause of age-related vision loss, a new WashU Medicine study in mice has shown. Pictured are color-stained retinal ...

How Does Eylea Work for Wet AMD? As you age, you may develop a condition that causes your vision to change. One of the most common eye conditions in older people is called age-related macular ...